Dopaminergic neuron therapy BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease

Discussion in 'Other health news and research' started by Jaybee00, Jul 28, 2021.

  1. Jaybee00

    Jaybee00 Senior Member (Voting Rights)

    Messages:
    2,035

Share This Page